461 related articles for article (PubMed ID: 36120320)
1. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC.
Cheng W; Li M; Zhang L; Zhou C; Yu S; Peng X; Zhang W; Zhang W
Front Pharmacol; 2022; 13():973116. PubMed ID: 36120320
[TBL] [Abstract][Full Text] [Related]
2. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
[TBL] [Abstract][Full Text] [Related]
3. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.
Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F
Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145
[TBL] [Abstract][Full Text] [Related]
4. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
Front Oncol; 2021; 11():635329. PubMed ID: 33928028
[TBL] [Abstract][Full Text] [Related]
5. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
6. Function and clinical significance of N6-methyladenosine in digestive system tumours.
Huang J; Shao Y; Gu W
Exp Hematol Oncol; 2021 Jul; 10(1):40. PubMed ID: 34246319
[TBL] [Abstract][Full Text] [Related]
7. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
8. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
9. Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers.
Li R; Yin YH; Ji XL; Liu X; Li JP; Qu YQ
Front Mol Biosci; 2021; 8():644620. PubMed ID: 34150845
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and therapeutic implication of m6A methylation in Crohn disease.
He Y; Hu Y; Yuan M; Xu W; Du Y; Liu J
Medicine (Baltimore); 2022 Dec; 101(51):e32399. PubMed ID: 36595818
[TBL] [Abstract][Full Text] [Related]
11. The role of N
Lu Z; Ma Y; Li Q; Liu E; Jin M; Zhang L; Wei C
Cell Stress Chaperones; 2019 Mar; 24(2):333-342. PubMed ID: 30701478
[TBL] [Abstract][Full Text] [Related]
12. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
Li D; Fu Z; Dong C; Song Y
Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574
[TBL] [Abstract][Full Text] [Related]
13. Role of N6-methyladenosine modification in pathogenesis of ischemic stroke.
Chang H; Yang J; Wang Q; Zhao J; Zhu R
Expert Rev Mol Diagn; 2022 Mar; 22(3):295-303. PubMed ID: 35236212
[TBL] [Abstract][Full Text] [Related]
14. The role of m6A modification in the biological functions and diseases.
Jiang X; Liu B; Nie Z; Duan L; Xiong Q; Jin Z; Yang C; Chen Y
Signal Transduct Target Ther; 2021 Feb; 6(1):74. PubMed ID: 33611339
[TBL] [Abstract][Full Text] [Related]
15. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Xie W; Ma LL; Xu YQ; Wang BH; Li SM
Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
[TBL] [Abstract][Full Text] [Related]
16. FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA.
Gan X; Dai Z; Ge C; Yin H; Wang Y; Tan J; Sun S; Zhou W; Yuan S; Yang F
Front Oncol; 2022; 12():989353. PubMed ID: 36172147
[TBL] [Abstract][Full Text] [Related]
17. THE ROLE OF N6-METHYLADENOSINE METHYLTRANSFERASE RBM15 IN NONALCOHOLIC FATTY LIVER DISEASE.
Li S; Lian S; Cheng W; Zhang T; Gong X
Shock; 2024 Feb; 61(2):311-321. PubMed ID: 38150369
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
[TBL] [Abstract][Full Text] [Related]
19. METTL16-mediated translation of
Tang J; Zhao X; Wei W; Liu W; Fan H; Liu XP; Li Y; Wang L; Guo J
PeerJ; 2022; 10():e14379. PubMed ID: 36518278
[TBL] [Abstract][Full Text] [Related]
20. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma.
Wu H; Dong H; Fu Y; Tang Y; Dai M; Chen Y; Wang G; Wu Y
Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):270-278. PubMed ID: 33006785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]